Opera (OPRA) stock soared 23% to $15.41 after beating Q4 estimates, unveiling a $300M buyback program, and issuing strong 2026 guidance. Full analysis here.
Performances in N.Y.C. Advertisement Supported by Exit Interview Graves, who gave her last performance on Saturday at the Met, talks about “Carmen,” the doctor who told her she would never sing again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results